PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 29208682-0 2017 The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ. Glutamine 44-53 EPH receptor A2 Homo sapiens 29-34 29208682-0 2017 The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ. Glutamine 44-53 Yes1 associated transcriptional regulator Homo sapiens 122-125 29208682-0 2017 The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ. Glutamine 44-53 tafazzin, phospholipid-lysophospholipid transacylase Homo sapiens 130-133 29208682-4 2017 We found that the receptor tyrosine kinase EphA2 activated the TEAD family transcriptional coactivators YAP and TAZ (YAP/TAZ), likely in a ligand-independent manner, to promote glutamine metabolism in cells and mouse models of HER2-positive breast cancer. Glutamine 177-186 Eph receptor A2 Mus musculus 43-48 29208682-4 2017 We found that the receptor tyrosine kinase EphA2 activated the TEAD family transcriptional coactivators YAP and TAZ (YAP/TAZ), likely in a ligand-independent manner, to promote glutamine metabolism in cells and mouse models of HER2-positive breast cancer. Glutamine 177-186 yes-associated protein 1 Mus musculus 104-107 29208682-4 2017 We found that the receptor tyrosine kinase EphA2 activated the TEAD family transcriptional coactivators YAP and TAZ (YAP/TAZ), likely in a ligand-independent manner, to promote glutamine metabolism in cells and mouse models of HER2-positive breast cancer. Glutamine 177-186 tafazzin, phospholipid-lysophospholipid transacylase Mus musculus 112-115 29208682-4 2017 We found that the receptor tyrosine kinase EphA2 activated the TEAD family transcriptional coactivators YAP and TAZ (YAP/TAZ), likely in a ligand-independent manner, to promote glutamine metabolism in cells and mouse models of HER2-positive breast cancer. Glutamine 177-186 yes-associated protein 1 Mus musculus 117-120 29208682-4 2017 We found that the receptor tyrosine kinase EphA2 activated the TEAD family transcriptional coactivators YAP and TAZ (YAP/TAZ), likely in a ligand-independent manner, to promote glutamine metabolism in cells and mouse models of HER2-positive breast cancer. Glutamine 177-186 tafazzin, phospholipid-lysophospholipid transacylase Mus musculus 121-124 29208682-7 2017 Silencing YAP or TAZ substantially reduced the amount of intracellular glutamate through decreased expression of SLC1A5 and GLS, respectively, genes that encode proteins that promote glutamine uptake and metabolism. Glutamic Acid 71-80 Yes1 associated transcriptional regulator Homo sapiens 10-13 29208682-7 2017 Silencing YAP or TAZ substantially reduced the amount of intracellular glutamate through decreased expression of SLC1A5 and GLS, respectively, genes that encode proteins that promote glutamine uptake and metabolism. Glutamic Acid 71-80 tafazzin, phospholipid-lysophospholipid transacylase Homo sapiens 17-20 29208682-7 2017 Silencing YAP or TAZ substantially reduced the amount of intracellular glutamate through decreased expression of SLC1A5 and GLS, respectively, genes that encode proteins that promote glutamine uptake and metabolism. Glutamic Acid 71-80 solute carrier family 1 member 5 Homo sapiens 113-119 29208682-7 2017 Silencing YAP or TAZ substantially reduced the amount of intracellular glutamate through decreased expression of SLC1A5 and GLS, respectively, genes that encode proteins that promote glutamine uptake and metabolism. Glutamine 183-192 Yes1 associated transcriptional regulator Homo sapiens 10-13 29208682-7 2017 Silencing YAP or TAZ substantially reduced the amount of intracellular glutamate through decreased expression of SLC1A5 and GLS, respectively, genes that encode proteins that promote glutamine uptake and metabolism. Glutamine 183-192 tafazzin, phospholipid-lysophospholipid transacylase Homo sapiens 17-20 29208682-7 2017 Silencing YAP or TAZ substantially reduced the amount of intracellular glutamate through decreased expression of SLC1A5 and GLS, respectively, genes that encode proteins that promote glutamine uptake and metabolism. Glutamine 183-192 solute carrier family 1 member 5 Homo sapiens 113-119